Integrated Symposia
Integrated Symposia slots are offered to industry as commercial/promotional sessions that are not CME accredited.
IS01
Organized by: Bruker Daltonik
MALDI-TOF in microbiology - routine identification and more
Saturday, 9 April 13:30 ̶ 15:30 h Hall B
IS02
Organized by: Siemens
New approaches in immunocompromised patients testing
Saturday, 9 April 13:30 ̶ 15:30 h Hall D
IS03
Organized by: AstraZeneca
Tackling the global epidemic of MDR Gram-negative bacteria: the evolving role of β-lactam/β-lactamase inhibitor combinations
Saturday, 9 April 13:30 ̶ 15:30 h Hall E
IS04
Organized by: MSD
Optimizing antifungal strategies to improve patient survival
Saturday, 9 April 13:30 ̶ 15:30 h Hall H
IS05
Organized by: Oxford Immunotec
TB & CMV immunodiagnostics: providing insight into immune-regulated conditions
Saturday, 9 April 16:30 ̶ 18:30 h Hall B
IS06
Organized by: QIAGEN
Harnessing the powers of PCR and IGRA to improve clinical insights in medical microbiology
Saturday, 9 April 16:30 ̶ 18:30 h Hall D
IS07
Organized by: MSD
Optimizing utilization of new antibiotics for MRSA infection management: targeted vs restrictive strategies
Saturday, 9 April 16:30 ̶ 18:30 h Hall H
IS08
Organized by: Pfizer Europe
Pneumococcal vaccination: a multidisciplinary perspective
Saturday, 9 April 16:30 ̶ 18:30 h Hall I
IS09
Organized by: Roche Diagnostics
The Power of Knowing: Better Solutions for Improved Patient Care
Sunday, 10 April 09:00 ̶ 11:00 h Hall B
IS10
Organized by: Astellas
The burden of recurrent C. difficile: fact or fiction?
Sunday, 10 April 09:00 ̶ 11:00 h Hall D
IS11
Organized by: Astrazeneca
Managing difficult-to-treat bacterial infections: clinical insights and experiences from the front line of ID care
Sunday, 10 April 09:00 ̶ 11:00 h Hall E
IS12
Organized by: Pfizer Europe
Patient pathways in difficult to treat infections*
*Complicated intra-abdominal infections (cIAI) and complicated skin and soft tissue infections (cSSTI) due to Gram+ and Gram- bacteria, invasive candidiasis/candidaemia, and invasive aspergillosis
Sunday, 10 April 09:00 ̶ 11:00 h Hall K
IS13
Organized by: MSD
Increased resistance, decreased options: how to improve outcomes against the most challenging Gram-negative bacterial infections
Sunday, 10 April 16:00 ̶ 18:00 h Hall B
IS14
Organized by: BioMerieux
From single to syndromic testing: the new paradigm in microbiology
Sunday, 10 April 16:00 ̶ 18:00 h Hall G
IS15
Organized by: Seegene
Advanced multiplex molecular diagnostics for respiratory and gastrointestinal tract infections
Sunday, 10 April 16:00 ̶ 18:00 h Hall H
IS16
Organized by: Basilea Pharmaceutica
New perspectives in the management of nosocomial pneumonia
Sunday, 10 April 16:00 ̶ 18:00 h Hall I
IS17
Organized by: Basilea Pharmaceutica
Invasive mould infections: current and recent developments
Monday, 11 April 09:00 ̶ 11:00 h Hall B
IS18
Organized by: MSD
Recurrent C. difficile infections: addressing clinical & economic consequences
Monday, 11 April 09:00 ̶ 11:00 h Hall C
IS19
Organized by: Astellas
The future of echinocandin therapy
Monday, 11 April 09:00 ̶ 11:00 h Hall E
IS20
Organized by: Cepheid
Accelerate the fight against Antimicrobial Resistance (AMR) with on-demand diagnostics
Monday, 11 April 09:00 ̶ 11:00 h Hall H
IS21
Organized by: Beckman Coulter
Emerging resistance and antimicrobial susceptibility testing
Monday, 11 April 16:00 ̶ 18:00 h Hall B
IS22
Organized by: Hologic
Successful diagnosis and management of often overlooked STIs
Monday, 11 April 16:00 ̶ 18:00 h Hall F
IS23
Organized by: Gilead
Antifungal stewardship: opportunities and challenges
Monday, 11 April 16:00 ̶ 18:00 h Hall K
IS24
Organized by: Beckman Coulter
Innovation in MDx: workflow redesign and assay performance
Tuesday, 12 April 09:00 ̶ 11:00 h Hall B
IS25
Organized by: Diasorin
Toxoplasma gondii, cytomegalovirus and Treponema pallidum infection in pregnancy: what's new?
Tuesday, 12 April 09:00 ̶ 11:00 h Hall H